The new coronavirus SARS-CoV-2 (COVID-19) continues to spread across the globe, affecting an increasing number of people and requiring the development of effective tools for disease prevention and treatment. The overwhelming majority of people infected with SARS-CoV-2 have an asymptomatic, mild or moderate course of the disease, and only 14% and 5% of patients develop a correspondingly severe or critical illness.
Higher rates of serious illness and death from COVID-19 infection in the elderly and those with comorbidities suggest that age- and disease-related biological processes make these individuals more sensitive to environmental stress and stress factors, including infectious agents such as coronavirus SARS-CoV-2. … ¹
The article was published in English by ACS Publications. The full article can be read here: Endogenous-Deficiency-of-Glutathione-in-COVID-19-Patients [PDF]
¹ACS Infect. Dis. 2020, 6, 7, 1558–1562 Publication Date:May 28, 2020
